Chemistry Research Laboratory, University of Oxford, Oxford, OX1 3TA, UK.
Chem Commun (Camb). 2020 May 21;56(41):5496-5499. doi: 10.1039/d0cc00444h.
Antisense oligonucleotides are now entering the clinic for hard-to-treat diseases. New chemical modifications are urgently required to enhance their drug-like properties. We combine amide coupling with standard oligonucleotide synthesis to assemble backbone chimera gapmers that trigger an efficient RNase H response while improving serum life time and cellular uptake.
反义寡核苷酸现在正进入难以治疗疾病的临床应用。为了增强它们的类药性,迫切需要新的化学修饰。我们将酰胺偶联与标准寡核苷酸合成相结合,组装具有骨架嵌合体间隔子的 Gapmer,在提高血清半衰期和细胞摄取的同时,触发有效的 RNase H 反应。